Protection & Privacy

Data Security & Processing Architecture

How We Protect Your Confidential Information

Your confidential deal data should never be at risk. Our secure, proprietary infrastructure ensures analytical depth without compromising data protection.

Our Architecture

Proprietary intelligence infrastructure with tiered security tailored to your engagement

Vantage Standard

Your data is analyzed using our proprietary analysis framework under enterprise-grade security protocols. Our database, scoring methodology, and analytical framework operate exclusively on Vantage infrastructure. Analytical queries are processed with zero data retention — nothing is stored beyond the duration of processing, and no client data is used for training, model improvement, or any external purpose.

Key Points:

  • ✓ Proprietary database never leaves Vantage infrastructure
  • ✓ Zero data retention on all analytical processing
  • ✓ AES-256 encryption in transit and at rest
  • ✓ Enterprise-grade security protocols (SOC 2 Type II on roadmap)

Vantage Secure PREMIUM

For clients requiring maximum data isolation, our Secure tier delivers complete end-to-end air-gapped processing. All analysis occurs on a physically isolated workstation with no network connectivity of any kind. Data is transferred exclusively via encrypted USB devices with chain-of-custody documentation.

Key Points:

  • ✓ Physically isolated workstation — zero network connectivity
  • ✓ LUKS full-disk encryption (AES-256)
  • ✓ Encrypted USB data transfer with chain-of-custody logs
  • ✓ DoD 5220.22-M secure deletion standard

Vantage Secure engagements carry a security infrastructure premium to cover air-gapped processing, encrypted transfer protocols, and enhanced chain-of-custody documentation. Secure tier adds 2-3 business days to standard timelines. See pricing on your service page or schedule a call to discuss your security requirements.

How We Handle Your Data

Strict protocols at every stage of the engagement

Stage Vantage Standard Vantage Secure
Intake Documents transferred via encrypted channel and stored on Vantage infrastructure. Documents transferred via encrypted USB with chain-of-custody log. Stored on air-gapped workstation.
Analysis MD + BME team conducts assessment using proprietary analysis framework. Zero data retention on all processing — no client data stored beyond query duration. MD + BME team conducts assessment on physically isolated infrastructure. No network connectivity. Complete air-gapped processing.
Delivery Final report delivered via encrypted transfer. Source documents retained for 90 days, then deleted per DoD 5220.22-M. Final report delivered via encrypted USB. Source documents deleted per DoD 5220.22-M with verified sanitization logs.
Post-Engagement Anonymized analytical insights (no identifying information) strengthen the proprietary analysis framework for future assessments.
On Request Source documents deleted at any time during or after engagement. Written confirmation within 5 business days.

Your engagement data is always under Vantage control. Our proprietary analysis framework — the database, methodology, and analytical framework — operates exclusively on our secure infrastructure. Vantage Standard delivers enterprise-grade protection with zero data retention. Vantage Secure provides complete air-gapped isolation for engagements requiring maximum security.

Our Proprietary Analysis Framework

Our proprietary platform for medical device due diligence

Our proprietary analysis framework identifies failure patterns — clinical adoption barriers, regulatory missteps, reimbursement gaps, manufacturing bottlenecks — that predict device outcomes. Built on secure, proprietary infrastructure with tiered security options.

In analysis of documented medical device outcomes curated from SEC filings, FDA records, and clinical literature, our scoring framework correctly classified investment risk in 96% of validated cases — and growing with every engagement.

Our database is continuously growing. Started with historical data from SEC filings, FDA records, and clinical literature — and strengthened with every new assessment engagement and the latest regulatory changes, market intelligence, and industry developments.

Proprietary DB
Documented Medical Device Outcomes
and growing with every engagement
18
Risk Categories
comprehensive assessment framework
96%
Risk Classification Accuracy
correctly classified investment risk across validated medical device outcomes
8
Device Categories
monitored and analyzed

Proprietary Database

Our proprietary database and analytical framework operate exclusively on Vantage-controlled infrastructure. Your data is analyzed within our secure environment.

Trade Secret Protected

Framework, weights, and pattern data maintained as proprietary intellectual property on secure infrastructure.

Continuously Improving

Every engagement adds validated data points to strengthen future analyses and detect emerging patterns.

Domain-Specific

Purpose-built for medical device due diligence using industry-specific failure mode taxonomy.

Always Current: Real-Time Regulatory Monitoring

Our proprietary analysis framework continuously tracks regulatory changes and incorporates them into live assessments

The regulatory landscape for medical devices shifts constantly. Our system monitors FDA guidance, compliance deadlines, and market-moving changes — and immediately flags these as risk factors in ongoing assessments.

February 2, 2026
FDA QMSR Compliance Deadline
The FDA's Quality Management System Regulation (QMSR) replaced the legacy QSR. Incorporates ISO 13485:2016 by reference with immediate compliance required — no transition period.
Flagged as critical compliance risk factor for all active assessments
June 27, 2025
FDA Cybersecurity Requirements Finalized
FDA converted cybersecurity from advisory guidance to enforceable requirements under Section 524B. Manufacturers of connected devices must now submit Software Bills of Materials (SBOM) with all premarket submissions.
Missing SBOM documentation now causes submission refusals
January 6, 2026
Clinical Decision Support & Wellness Guidance
FDA expanded scope of products exempt from regulation, creating new market opportunities but narrowing regulatory pathways startups must navigate.
Impacts device classification and market access strategy assessment

Compliance & Standards

Industry-standard protections and third-party verification

🔐

AES-256 Encryption

All data encrypted at rest and in transit using military-grade encryption standards

⚖️

HIPAA Framework

Technical safeguards aligned with HIPAA Security Rule requirements

🛡️

DoD 5220.22-M

Secure data deletion standard for source documents and materials

📅

90-Day Retention

Client source documents deleted within 90 days of delivery

SOC 2 Roadmap

Type II certification targeted for Year 3 of operations

🔍

Annual Security Review

Third-party assessment of data handling procedures

Your Data Rights

Complete control and transparency over your information

  • Request deletion of source documents at any time during or after your engagement

  • Receive written confirmation of deletion within 5 business days

  • Verify our data handling — processing is governed by strict data security protocols on Vantage-controlled infrastructure

  • Review sanitization logs for your engagement to understand exactly what was processed

  • Request a copy of all data we hold about your engagement

Questions About Our Data Security Practices?

We're transparent about how we protect your information. Speak directly with our team about your data security requirements.

Schedule a Security Briefing
Schedule a Call